IRF4 and aneurysmal bone cyst: For example, lenalidomide which induces IRF4 levels decrease [45], and ibrutinib which targets B-cell receptor signaling (Wilson WH et al., 2012, ASH Annual Meeting Abstract) have shown promising results in extracerebral ABC-DLBCL.